LIFE · Ethos Technologies
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $45.54
Note written ·
Price against the kill line
27.0% clear of its kill line on the 13 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $45.54, on record since 11 November 2026. The shares are down 5.4% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $45.54, about 21% over the 11 November 2026 close and above the $43.39 pre-report close, which would show the shares leading the S&P 500. A raised FY2026 outlook or fourth-quarter revenue above the $224 million top of guidance would also prove the call wrong.
Research onlyNot in the portfolio.
Key figures from the filings · Financials
Quarter to 30 September 2026, filed 4 November 2026; valuation at the 13 November 2026 close
- Revenue, latest quarter ($M)
- 235
- Revenue, change on a year (%)
- +150.8
- Gross margin (%)
- 98.1
- Operating margin (%)
- 1.6
- Free cash flow, four quarters ($M)
- 111
- Net cash, cash less debt ($M)
- 222
- Enterprise value to sales (×)
- 2.9
- Free-cash-flow yield (%)
- 4.8
All filed numbers
What Ethos Technologies reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Gross margin (%) | Operating margin (%) |
|---|---|---|---|---|
| first filed | 235 | +150.8 | 98.1 | 1.6 |
| first filed | 190 | +113.4 | 97.9 | 9.6 |
| first filed | 193 | +103.5 | 98.3 | −84.6 |
| first filed | 110 | — | 98.1 | 22.2 |
| first filed | 93.8 | — | 98.2 | 18.2 |
| first filed | 88.8 | — | 98.4 | 21.2 |
| Pre-tax income ($M) | 5.5 |
| Net income ($M) four quarters: −118 | 4.7 |
| Diluted shares, change on a year (%) against the quarter to 30 September 2025 | +18.9 |
| Operating cash flow ($M) | 113 |
| Capital spending ($M) | 1.7 |
| Free cash flow ($M) | 111 |
| Cash and short-term investments ($M) | 222 |
| Debt ($M) | None reported |
| Net cash, cash less debt ($M) no debt reported | 222 |
| Deferred revenue ($M) | 0.0 |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | 83.5 |
| Inventory ($M) | Not reported |
| Shareholders' equity ($M) | 512 |
| Market value ($M) | 2,302 |
| Enterprise value, market value plus net debt ($M) no debt reported | 2,080 |
| Enterprise value to sales (×) no debt reported | 2.9 |
| Enterprise value to operating income (×) | Not meaningful |
| Price to earnings (×) | Not meaningful |
| Price to book value (×) | 4.5 |
| Free-cash-flow yield (%) | 4.8 |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 5.9% of shares outstanding sold short, 2.9 days of average trading to cover, +10.9% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $28.2M |
| 12 monthsfrom | $10.0M | $94.9M |
The thesis
Ethos Technologies' shares look more likely to lag the S&P 500 over the next three months. Record third-quarter growth came mostly from the agency channel that short sellers dispute. Commissions receivable and insider selling also kept rising. The next customer-concentration disclosure and the fourth-quarter results will show whether third-party growth is durable.
The company reported on 2 November 2026. Revenue was $235.2 million, against the company's own $160–164 million outlook. The shares still fell from a $43.39 close on 30 October 2026 to a $32.62 close on 5 November 2026. They then recovered to close at $37.64 on 11 November 2026, per adjusted daily closes.
The growth changed character. Direct revenue barely moved, from $116.5 million in the second quarter to $118.8 million in the third. Third-party revenue rose from $73.1 million to $116.4 million over the same period, per the company's releases.
The 10-Q, filed on 4 November 2026, shows the receivable building on the long-dated side. Non-current commissions receivable reached $315.4 million on 30 September 2026, up from $224.2 million on 31 December 2025. The current portion rose to $33.9 million from $28.8 million. The rating is Low because the rebound has not recovered the pre-report close, and no filing has yet answered the concentration question.
Bullish and bearish views on Ethos Technologies Inc.
The bull case on Ethos Technologies Inc. (LIFE), in brief: the beat was very large. The bear case: growth leaned on the disputed channel.
Bull case
- The beat was very large. Third-quarter revenue of $235.2 million rose 151% year over year, per the 2 November 2026 8-K, against a $165.758 million consensus cited by Benzinga. Adjusted earnings per share were $0.49 against a $0.30 estimate.
- Guidance rose well above estimates. On 2 November 2026 the company guided fourth-quarter revenue to $220–224 million, against a $185.701 million estimate cited by Benzinga. Full-year guidance moved to $838–842 million from $727–731 million.
- Policy volume surged. New policies activated reached 142,111 in the third quarter, up 189% year over year, per the 8-K.
- Cash generation continued. Operating cash flow was $40.7 million in the third quarter and $107.6 million over nine months. Cash and investments totaled $290.1 million on 30 September 2026, per the 8-K.
- Analyst targets sit above the price. Citi raised its target to $61 on 4 November 2026, and Baird and Citizens raised theirs to $55 on 3 November 2026, according to Benzinga. Barclays' target is $44, and fiscal.ai reported a $45 consensus 12-month target on 5 November 2026.
- The direct channel added a carrier partner. Ethos and Liberty Mutual announced an expanded partnership on 28 October 2026 that offers life insurance with cross-product savings to eligible customers.
- A buyback is available. The board authorized up to $100 million of Class A repurchases. The 2 November 2026 8-K says no shares had been bought since the announcement.
Bear case
- Growth leaned on the disputed channel. Third-party revenue rose 209% year over year to $116.4 million in the third quarter, nearly level with direct revenue of $118.8 million. Hunterbrook's 1 October 2026 investigation says three agencies made up about 31% of revenue in the 2025 annual report, up from 17% in 2023. Hunterbrook discloses a short position.
- Receivables grew mostly in later years. Non-current commissions receivable rose to $315.4 million on 30 September 2026 from $224.2 million on 31 December 2025, per the 10-Q filed on 4 November 2026. That is cash the company books as revenue now and collects in later years.
- Revenue per policy and margins fell. Average revenue per unit dropped 13% year over year to $1,655, which the 8-K attributes mainly to channel mix. A Seeking Alpha analysis titled "Bigger Beats, Thinner Margins" says the mix cut the adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) margin to 15% from 19%.
- GAAP profit trailed the adjusted figures. Third-quarter net income under generally accepted accounting principles (GAAP) was $4.7 million, or $0.07 per share, down from $19.5 million in the second quarter. Non-GAAP net income was $33.8 million, per the 8-K.
- Guidance implies a sequential decline. The $220–224 million fourth-quarter outlook sits below third-quarter revenue of $235.2 million.
- Executives are steady sellers near the current price. SEC Form 4 filings show CEO Peter Colis sold 120,000 shares between 14 October 2026 and 16 October 2026 at an average of $38.39. President Lingke Wang sold 118,333 shares on 15 October 2026 at an average of $38.36. Both sales were under Rule 10b5-1 plans and followed similar sales on 16 September to 18 September 2026.
- Legal questions remain open. Pomerantz LLP said on 29 October 2026 that it is investigating possible securities claims tied to the Hunterbrook report. Hunterbrook also says it found 28 agents with active Ethos sales pages whose licenses had been suspended or revoked.
Price setup
The shares closed at $37.64 on 11 November 2026, just under the 50-day moving average of $38.07, per adjusted daily closes. That leaves them up 8.2% over three months.
The case turns on three levels. The $32.62 close on 5 November 2026 is the post-report low, and it sits close to the $32.57 close of 1 October 2026, the day the Hunterbrook and second Bear Cave reports came out. The $43.39 close on 30 October 2026 is the last price before the report. Barclays' $44 target and the $45 consensus target from fiscal.ai sit just above that close.
Executive sales in September and October averaged between $38.36 and $38.96 a share, per SEC Form 4 filings. That range is just above the 11 November 2026 close. The IPO lock-up has fully expired, so pre-IPO holders can also sell freely.
Catalysts ahead
- ~1 March 2027 (est.): Fourth-quarter FY2026 results. Tests revenue against the $220–224 million outlook and adjusted EBITDA against $30–32 million. Revenue above the top of the range would show the agency-driven growth holding.
- ~15 March 2027 (est.): FY2026 annual report (10-K). Updates the customer-concentration figure that Hunterbrook put at about 31% for 2025. It also shows the year-end commission receivable schedule.
What would change the view
A daily close above $45.54, about 21% over the 11 November 2026 close and above the $43.39 pre-report close, which would show the shares leading the S&P 500. A raised FY2026 outlook or fourth-quarter revenue above the $224 million top of guidance would also prove the call wrong.
What it trades with
The shares trade on company-specific questions: agency concentration, receivables and the short reports. The fall after 2 November 2026 came alongside record results, which points to stock-specific selling rather than a market move. The shares listed in January 2026, too recently to measure a reliable link to any index or sector. Insurance-distribution and consumer-fintech peers may share sentiment, but the agency dispute is particular to Ethos.
The evidence, claim by claim (8)
- Third-quarter revenue was $235.2 million, up 151% year over year; direct revenue was $118.8 million, up 112%, and third-party revenue was $116.4 million, up 209%. Ethos Form 8-K, Exhibit 99.1, 2 November 2026 · as of
- The company guided fourth-quarter revenue to $220–224 million and adjusted EBITDA to $30–32 million; FY2026 guidance became $838–842 million revenue and $134–136 million adjusted EBITDA. Ethos Form 8-K, Exhibit 99.1, 2 November 2026 · as of
- Third-quarter net income was $4.7 million, non-GAAP net income was $33.8 million, adjusted EBITDA was $34.9 million at a 15% margin, and operating cash flow was $40.7 million. Ethos Form 8-K, Exhibit 99.1, 2 November 2026 · as of
- Non-current commissions receivable was $315.4 million and the current portion $33.9 million on 30 September 2026, against $224.2 million and $28.8 million on 31 December 2025. Ethos Form 10-Q for the quarter ended 30 September 2026, filed 4 November 2026 · as of
- New policies activated were 142,111, up 189% year over year; average revenue per unit was $1,655, down 13%, mainly because of channel mix. Ethos Form 8-K, Exhibit 99.1, 2 November 2026 · as of
- Citi raised its price target to $61; Baird and Citizens raised theirs to $55 and Barclays to $44 after the third-quarter report. Benzinga analyst headlines, 3 November 2026 and 4 November 2026 · as of
- CEO Peter Colis sold 120,000 shares at an average of $38.39 on 14 October to 16 October 2026, and President Lingke Wang sold 118,333 at an average of $38.36 on 15 October 2026, both under Rule 10b5-1 plans. SEC Form 4 filings, 16 October 2026 · as of
- Hunterbrook says three agencies made up about 31% of Ethos revenue in the 2025 annual report, up from 17% in 2023; Hunterbrook discloses a short position. Hunterbrook investigation, hntrbrk.com/investigations/ethos · as of
Sources
- Ethos Technologies Inc. - Form 8-K - FY2026 · sec.gov ·
- Ethos Technologies Inc. - Form 10-Q - FY2026 · sec.gov
- Ethos Technologies Analysts Boost Their Forecasts After Upbeat Q3 Results · benzinga.com
- Ethos Technologies Inc. Class A Common Stock (NASDAQ:LIFE) Stock Price Expected to Rise, Citigroup Analyst Says · marketbeat.com ·
- Ethos Technologies Inc. Class A Common Stock (NASDAQ:LIFE) Price Target Raised to $44.00 · dailypolitical.com ·
- Ethos Technologies: Bigger Beats, Thinner Margins (NASDAQ:LIFE) · seekingalpha.com
- Ethos Technologies Inc (LIFE) Stock Price & News · google.com
Related · shared themes
CVNA
Carvana
Carvana is taking share in a flat used-car market, with third-quarter retail units up 39% and more units guided for the fourth quarter. The…
EVER
EverQuote
EverQuote's third-quarter revenue of $218.1 million and adjusted EBITDA of $35.5 million beat the top of its guidance, giving the shares a…
NU
Nu Holdings
Nu Holdings shares are more likely to lag the S&P 500 over the next three months, as rising 90-day delinquencies and a post-election Brazil…
UPST
Upstart Holdings
Upstart Holdings is more likely to lag the S&P 500 over the next three months: it cut its 2026 outlook and October lending slowed. November…
See also · stocks to watch